Komori
Other Disclosures4880CellSource Co.,Ltd.Pharmaceuticals

Notice of an Employee Speaking at a C-FORTE-Hosted Webinar for Physical Therapists

A CellSource employee will speak at a webinar for physical and occupational therapists hosted by C-FORTE, a business partner. The employee is scheduled to explain regenerative medicine, PFC-FD™, and collaboration with rehabilitation.

Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

PFC-FD™
Applicable field (uses covered by this announcement)

Regenerative medicine and related treatments, rehabilitation, self-pay medical care at medical institutions, and education for physical and occupational therapists

Launch date28 September 2026 (Mon), 20:00-21:00 (scheduled)
What the company reported numerically
Usage history

CellSource has undertaken the processing of more than 130,000 cell-based products and related materials

Relationship between the counterparty and the company
CellSource Co.,Ltd.4880
Relationship with the Company

Business partnership. Education and awareness activities are being promoted under the business partnership.

CounterpartyC-FORTE Co., Ltd.

511-1 Hachimancho, Ashikaga, Tochigi. The representative director and president is Noguchi Kei (野口 慧). The company provides rehabilitation following regenerative medicine and related treatments, consulting services for medical institutions, and career support for physical therapists.

Registration number and expiry date

Facility number of CellSource’s licensed facility for manufacturing specified cell-processed products and related products: FA3240004. Expiry date: not disclosed

Location (as indicated in this announcement)

CellSource headquarters: Shibuya Cast 11F, 1-23-21 Shibuya, Shibuya-ku, Tokyo. C-FORTE headquarters: 511-1 Hachimancho, Ashikaga, Tochigi

Offering price

Free of charge

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredPFC-FD™
CounterpartyC-FORTE Co., Ltd.
Counterparty overview511-1 Hachimancho, Ashikaga, Tochigi. The representative director and president is Noguchi Kei (野口 慧). The company provides rehabilitation following regenerative medicine and related treatments, consulting services for medical institutions, and career support for physical therapists.
Relationship with the CompanyBusiness partnership. Education and awareness activities are being promoted under the business partnership.
Offering priceFree of charge
Launch date28 September 2026 (Mon), 20:00-21:00 (scheduled)
Applicable areaRegenerative medicine and related treatments, rehabilitation, self-pay medical care at medical institutions, and education for physical and occupational therapists
Registration number and expiry dateFacility number of CellSource’s licensed facility for manufacturing specified cell-processed products and related products: FA3240004. Expiry date: not disclosed
LocationCellSource headquarters: Shibuya Cast 11F, 1-23-21 Shibuya, Shibuya-ku, Tokyo. C-FORTE headquarters: 511-1 Hachimancho, Ashikaga, Tochigi
Usage historyCellSource has undertaken the processing of more than 130,000 cell-based products and related materials
Items this document does not state (8)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyLocation scaleQuantitative EffectsImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

As part of efforts to promote education and awareness under the business partnership with C-FORTE, to deepen healthcare professionals’ understanding and strengthen information sharing and support for clinical practice.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of an Employee Speaking at a C-FORTE-Hosted Webinar for Physical Therapists | CellSource Co.,Ltd. (4880) timely disclosure | Komori